04/15/2024
3:49 PM | Tonix Pharmaceuticals (Filer)
| Form ARS | |
04/15/2024
3:38 PM | Tonix Pharmaceuticals (Filer)
| Form DEF 14A | |
04/05/2024
3:47 PM | Tonix Pharmaceuticals (Filer)
| Form PRE 14A | |
03/29/2024
4:28 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
03/29/2024
4:16 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
8:03 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
8:23 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/20/2024
8:48 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
7:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:01 PM | LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4/A | |
03/06/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
4:05 PM | SULLIVAN GREGORY M (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:06 PM | MORRIS JESSICA EDGAR (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:07 PM | SAENGER BRADLEY (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:08 PM | LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
7:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
7:07 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
6:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
6:00 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
3:31 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2024
3:53 PM | Empery Asset Management, LP (Filed by)
Tonix Pharmaceuticals (Subject)
| Form SC 13G | |
01/08/2024
4:07 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
3:33 PM | Tonix Pharmaceuticals (Filer)
| Form DEF 14A | |
01/02/2024
3:15 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
4:04 PM | Tonix Pharmaceuticals (Filer)
| Form PRE 14A | |
12/26/2023
4:25 PM | Tonix Pharmaceuticals (Filer)
| Form DEF 14A | |
12/21/2023
4:28 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
12/21/2023
4:15 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
12/21/2023
4:04 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
9:31 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
6:00 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
4:14 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
6:10 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
3:23 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Stock-Picking AI Predicts #1 Stock of 2024 (Ad) Since the start of the year, the top 10 investment funds in the world – including Vanguard, Blackrock, Fidelity and JP Morgan – have made nearly $1 trillion in profits on these 7 stocks. Click here to learn what's coming (and how to prepare). |
11/09/2023
3:27 PM | Tonix Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
6:49 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/26/2023
6:17 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
3:53 PM | Tonix Pharmaceuticals (Filer)
| Form PRE 14A | |
10/20/2023
4:07 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2023
3:32 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2023
3:15 PM | Tonix Pharmaceuticals (Filer)
| Form 424B4 | |
09/29/2023
3:16 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2023
7:35 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2023
3:36 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/21/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
7:28 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
8:15 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
7:31 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2023
6:07 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
6:51 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2023
6:15 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2023
7:35 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2023
6:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
7:30 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2023
6:30 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2023
4:24 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K/A | |
07/17/2023
6:12 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2023
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2023
4:05 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2023
7:17 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
4:12 PM | Tonix Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/15/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
4:29 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/01/2023
6:01 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2023
6:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/25/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
4:13 PM | GRANGE DAVID L (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
4:14 PM | Bell Margaret Smith (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
4:15 PM | BAGGER RICHARD H (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2023
12:05 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The asset beating inflation by 4x (Ad) "Trump Loophole" Beats Inflation?
Inflation has been out of control for years.
Forcing you to work longer and harder for more money that is worth less.
By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties. That's why we have released our Free Precious Metals Investment Guide that explains all the details |
